首頁 > 市場調查報告書 > 製藥

生技設備生物工藝

市場調查報告書

商品編碼

1634625

生物加工袋市場：現況分析與未來預測（2024-2032）

Bioprocess Bags Market: Current Analysis and Forecast (2024-2032)

出版日期: 2024年12月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 154 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計預測期內（2024-2032 年），生物處理袋市場將以 17.5% 的顯著複合年增長率成長。生物處理袋市場的成長反映了全球生物製藥製造中使用一次性技術的趨勢。這些產業享有許多好處，例如縮短了交貨時間、降低了污染機率、提高了生產力。生物處理袋市場的擴張是由對生物製劑、生物相似藥和疫苗的不斷增長的需求所推動的。 2022 年 10 月，奧地利解決方案供應商 Single Use Support GmbH 擴大了產品組合，推出了一系列名為 IRIS 的新型一次性生物處理容器。作為先驅者，該公司繼續推行與供應商無關的方法，利用其專業知識在生物製藥流體管理領域提供可靠的流程解決方案。

根據類型，市場分為 2D 生物處理袋、3D 生物處理袋和其他。其中，2D 生物處理袋將在 2023 年佔據市場的主導佔有率，因為 2D 生物處理袋解決方案將透過生物製藥製造中經濟且節省空間的流體管理推動成長。生物製藥製造中的流體管理經濟且節省空間，由於生物製藥製造中流體管理的經濟性和空間效率，推動了成長。這些解決方案適用於在您的製程中儲存和運輸培養基、緩衝液和中間產品，具有完全無菌性和靈活性。例如，2023 年 7 月，醫療和生物製藥行業 OEM 一次性組件的全球供應商 Qosina 宣佈已收購 Entegris 的 Aramus 2D 袋，後者是半導體和其他高高科技製造業。。

根據產品類型，市場分為一次性生物處理袋和多次使用生物處理袋。一次性生物處理袋受生產規模快速擴大、清潔頻率減少和交叉污染風險低的推動，在 2023 年佔據了相當大的市場佔有率。此外，由於它們對培養基製備、混合和產品儲存等生物加工的適應性，公司正在生物加工中使用這些袋子。它對自動化生物反應器和封閉系統的適應性使其成為現代生物製造業的基石。例如，2022 年 3 月 28 日，專門為生物製藥和製藥加工提供創新一次性解決方案的 ILC Dover LP（ "ILC Dover" 或 "公司" ）宣佈推出其液體一次性生物處理袋。宣佈。此次擴展延續了 ILC Dover 的解決方案集，涵蓋了整個生物治療和製藥製造工作流程，從粉末容納和處理到無菌液體處理和預填充液體和粉末袋。

根據工作流程，市場分為上游處理、下游處理、流程開發和媒體準備。預計預測期內（2024-2032 年），下游加工將以顯著的複合年增長率成長。下游加工的這一環節透過為製程的產品淨化步驟提供安全有效的多產品流體處理解決方案來促進成長。組織使用這些袋子來最大限度地減少營運中斷並促進符合高標準品質的生產。與色譜和過濾結合，可以提高生物製劑的產量和純度。

根據最終用戶，市場細分為製藥和生物製藥公司、CMOS 和 CROS 以及學術和研究機構。預計 CMOS/CROS 在預測期內（2024-2032 年）將以顯著的複合年增長率成長。 CMO/CRO是[CRO（合約研究組織）/CMO（合約製造組織）]的縮寫，並引入生物加工袋，以大規模和實惠的價格提供生物加工生產服務。這些組織依賴一次性系統（如生物製程袋），因為它們在生物製劑和生物相似藥的生產中具有多功能性。

為了更瞭解生物工藝袋的市場介紹，該報告涵蓋了北美（美國、加拿大和北美其他地區）、歐洲（德國、法國、英國、西班牙、義大利和歐洲其他地區）、亞太地區（中國、日本、韓國、印度、亞太地區其他地區）和其他地區的全球影響力是市場分析的基礎。預計預測期內（2024-2032 年）亞太地區將實現顯著的複合年增長率。這是由於中國和印度等新興強國的生物技術產業蓬勃發展以及生物製藥消費量激增。由於政府政策支持低製造成本的本地生產，該地區是最重要的生物加工中心之一。增加一次性技術的支出和透過 CMO/CRO 增加 CMC 服務的外包是關鍵推動因素。公司選擇遵守生物加工袋的國際品質標準的原因有很多，其中包括擴大生物相似藥和疫苗生產規模的需要。此外，該地區對新技術和出口導向生物製造的關注進一步支持了其採用。 2021 年6 月1 日，Avantor, Inc. (NYSE: AVTR) 是一家為生命科學、先進技術和應用材料行業的客戶提供關鍵任務產品和服務的全球領先供應商，今天宣佈已收購Avantor, Inc 的一家子公司.，一家全資子公司...宣佈收購中國領先的一次性生物處理袋和組件製造商 RIM Bio。

市場包括Thermo Fisher Scientific Inc.、Sartorius AG、Merck KGaA、Saint-Gobain、Avantor, Inc.、Corning Incorporated、Lonza Group Ltd.、Entegris、Meissner Filtration Products, Inc.、Charter Medical (Solesis)等。

Bioprocess bags are disposable polymeric sacks used in the processing, storage, and transportation of the liquid or media in biopharmaceutical industries. These bags help maintain sterility, are scalable, and engraved to reduce contamination. This includes upstream and downstream processes when producing chemicals and the final formulation stage with high-quality polymer material. They are essential to all current bioprocessing strategies due to the productivity and, even more so, the affordability of these supports.

The Bioprocess Bags Market is expected to grow with a significant CAGR of 17.5% during the forecast period (2024-2032). The growth of the bioprocess bags market reflects the global trend towards the usage of single-use technologies in biopharmaceutical production. These industries avail themselves by minimized lead time, decreased probability of contamination, and improved production. The bioprocess bags market expansion is fueled by the increasing need for biologics, biosimilars, and vaccines. In October 2022, Austrian solution provider Single Use Support GmbH expanded its product portfolio with new single-use bioprocess containers under the brand name IRIS. The pioneering company leverages its know-how to provide reliable process solutions in the field of biopharmaceutical fluid management, continuing to pursue its vendor-agnostic approach.

Based on the type, the market is segmented into 2D Bioprocess Bags, 3D Bioprocess Bags, and others. Among these, 2D Bioprocess Bags held a dominant share of the market in 2023 because the solutions of the 2D bioprocess bags promote growth through economical and space-efficient fluid management in biopharmaceutical production. They are suitable to be used for storage and transportation of media, buffers as well as intermediate products in the process with total sterility and flexibility. For instance, in July 2023, Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, announced the addition of Aramus 2D bag chambers from Entegris, a leading supplier of advanced materials and process solutions for semiconductors and other high-tech manufacturing industries.

Based on product type, the market is segmented into single-use bioprocessing bags and multi-use bioprocessing bags. Single-use bioprocessing bags held a significant share of the market in 2023 owing to enhanced growth by facilitating rapid production scaling, the need to clean them less often, and possessing lower risk of cross-contamination. Adding to this, companies use these bags in bioprocessing due to their adaptability to bioprocesses such as media preparation, mixing, and product storage. Their adaptability to automated bioreactors and closed systems makes them fundamental to the current biomanufacturing industry. For instance, on March 28, 2022 - ILC Dover LP ("ILC Dover" or the "Company"), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced its launch of liquid single-use bioprocessing bags, representing the first of many new products for handling and supply of sterile liquids for the biotherapeutics market. This expansion is a continuation of ILC Dover's solution set across the entire biotherapeutic and pharmaceutical manufacturing workflow, from powder containment and handling, through sterile liquid handling and pre-filled liquid and powder bags.

Based on the workflow, the market is segmented into upstream process, downstream process, process development, and media preparation. The downstream process is expected to grow with a significant CAGR during the forecast period (2024-2032. This segment in downstream processing enables growth by providing safe and effective multi-product fluid-handling solutions for product purification steps in the process. These bags are embraced in organizations to minimize pauses in operation and facilitate production to meet high standard quality. In combination with chromatography and filtration, it raises the production yield and purity of biological products.

Based on the end user, the market is segmented into pharmaceutical & biopharmaceutical companies, CMOS & CROS, and academic & research institutes. The CMOS & CROS is expected to grow with a significant CAGR during the forecast period (2024-2032. CMOs/CROs stands [Contract research organizations (CROs), contract manufacturing organizations (CMOs)] enable growth through the implementation of bioprocess bags for contained bioprocessing of production services at scale and affordable rates. These organizations depend on single-use systems - such as bioprocess bags - as these provide production versatility in biologics and biosimilars.

For a better understanding of the market adoption of Bioprocess Bags, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, U.K., Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia-Pacific is expected to grow with a significant CAGR during the forecast period (2024-2032). This is due to the booming biotechnology industry and rapidly growing consumption of biopharma products in the region's emerging giants such as China and India. It is one of the most important bioprocessing locations because government policies support the production of local goods along with cheaper manufacturing expenses. Increased spending on single-use technologies and increasing outsourcing of CMC services through more CMOs/CROs are critical drivers. There are several reasons companies opt for bioprocess bags compliance with international quality standards and the need to scale up biosimilars and vaccine production. The region's emphasis on new technologies and export-oriented biomanufacturing also drives adoption even more. On June 1, 2021, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries, announced that it has acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

Some of the major players operating in the market include Thermo Fisher Scientific Inc.; Sartorius AG; Merck KGaA; Saint-Gobain; Avantor, Inc.; Corning Incorporated; Lonza Group Ltd.; Entegris; Meissner Filtration Products, Inc.; Charter Medical (Solesis).

1.MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Bioprocess Bags Market
2.2. Research Methodology of the Bioprocess Bags Market
2.3. Respondent Profile

3.EXECUTIVE SUMMARY

3.1. Industry Synopsis
3.2. Segmental Outlook
- 3.2.1. Market Growth Intensity
3.3. Regional Outlook

4.MARKET DYNAMICS

4.1. Drivers
4.2. Opportunity
4.3. Restraints
4.4. Trends
4.5. PESTEL Analysis
4.6. Demand Side Analysis
4.7. Supply Side Analysis
- 4.7.1. Merger & Acquisition
- 4.7.2. Investment Scenario
- 4.7.3. Industry Insights: Leading Startups and Their Unique Strategies

5.PRICING ANALYSIS

5.1. Regional Pricing Analysis
5.2. Price Influencing Factors

6.GLOBAL BIOPROCESS BAGS MARKET REVENUE (USD BN), 2022-2032F

7.MARKET INSIGHTS BY TYPE

7.1. 2D Bioprocess Bags
7.2. 3D Bioprocess Bags
7.3. Others

8.MARKET INSIGHTS BY PRODUCT TYPE

8.1. Single-Use Bioprocessing Bags
8.2. Multi-Use Bioprocessing Bags

9.MARKET INSIGHTS BY WORKFLOW

9.1. Upstream Process
9.2. Downstream Process
9.3. Process Development
9.4. Media preparation

10.MARKET INSIGHTS BY END USER

10.1. Pharmaceutical & Biopharmaceutical Companies
10.2. CMOs & CROs
10.3. Academic & Research Institutes

11.MARKET INSIGHTS BY REGION

11.1. North America
- 11.1.1. U.S.
- 11.1.2. Canada
- 11.1.3. Rest of North America
11.2. Europe
- 11.2.1. Germany
- 11.2.2. France
- 11.2.3. UK
- 11.2.4. Spain
- 11.2.5. Italy
- 11.2.6. Rest of Europe
11.3. Asia-Pacific
- 11.3.1. China
- 11.3.2. Japan
- 11.3.3. India
- 11.3.4. Rest of APAC
11.4. Rest of the World

12.VALUE CHAIN ANALYSIS

12.1. List of Market Participants

13.COMPETITIVE LANDSCAPE

13.1. Competition Dashboard
13.2. Competitor Market Positioning Analysis
13.3. Porter Five Forces Analysis

14.COMPANY PROFILES

14.1. Thermo Fisher Scientific Inc.
- 14.1.1. Company Overview
- 14.1.2. Key Financials
- 14.1.3. SWOT Analysis
- 14.1.4. Product Portfolio
- 14.1.5. Recent Developments
14.2. Sartorius AG
14.3. Merck KGaA
14.4. Saint-Gobain
14.5. Avantor, Inc.
14.6. Corning Incorporated
14.7. Lonza Group Ltd.
14.8. Entegris
14.9. Meissner Filtration Products, Inc.
14.10. Charter Medical (Solesis)